Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research

Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies, observational in design, appear to use biased methods that can distort the interaction between RAAS inhibitor use and COVID‐19 risk. This study assessed the extent of bias in that research and reevaluated RAAS inhibit...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2022-06-01
Col·lecció:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Matèries:	angiotensin receptor blockers angiotensin‐converting enzyme inhibitors calcium channel blockers COVID‐19 renin‐aldosterone angiotensin system inhibitors thiazide diuretics
Accés en línia:	https://www.ahajournals.org/doi/10.1161/JAHA.122.025289
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!